1
|
Lu W, Liu J, Luo M, Xiao M. Relationship between Monoclonal Gammopathy of undetermined significance and multiple myeloma via online database analysis. Pak J Med Sci 2023; 39:715-720. [PMID: 37250588 PMCID: PMC10214783 DOI: 10.12669/pjms.39.3.7206] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/03/2022] [Revised: 11/05/2022] [Accepted: 02/08/2023] [Indexed: 11/02/2023] Open
Abstract
Objective To explore the relationship between Monoclonal Gammopathy of undetermined significance (MGUS) and Multiple Myeloma (MM) based on bioinformatics methods. Methods In this study, we conducted bioinformatics to identify genes associated with MGUS and MM using the PubMed pubmed2ensemble (http://pubmed2ensembl.ls.manchester. ac.uk/) until 2021. Gene ontology function was used to label overlapping genes, and Kyoto Encyclopedia of Genes and Genomes analysis was used to identify enriched pathways. The cluster-1 genes obtained from Cytoscape were analyzed by Comparative Toxicogenomics Database (CTD, http://ctdbase.org/) and then used to screen candidate drugs using the DSigDB database (https://amp.pharm.mssm.edu/Enrichr/). Results In total, 227 genes were common to both MGUS and MM. These genes were significantly associated with cytokine-cytokine receptor interaction and the PI3K-Akt signaling pathway. The protein-protein interaction network revealed that TNF, IL-1B, IL-6, CSF2, CXCL8, and IL-10 were among the core genes of MM. Finally, eight candidate drugs showed maximum interaction with core genes, which could potentially prevent MGUS from progressing to MM. Conclusion The progression of MGUS to MM is driven by aberrant cytokine secretion, which leads to inflammation immune dysfunction, and dysregulation of the PI3K/AKT/mTOR signaling pathway.
Collapse
Affiliation(s)
- Weiguo Lu
- Weiguo Lu, Clinical Laboratory, The First Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou 510405, China
| | - Jiaming Liu
- Jiaming Liu, The Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou 510405, China
| | - Man Luo
- Man Luo, Hematology Department, The First Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou 510405, China
| | - Mingfeng Xiao
- Mingfeng Xiao, Clinical Laboratory, The First Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou 510405, China
| |
Collapse
|
2
|
Zhang XW, Wald A, Salzmann M, Halama N, Hassel JC. Cytokine alterations during paraneoplastic neutrophilia and leukemoid reaction in patients with advanced melanoma. Cancer Immunol Immunother 2023; 72:509-513. [PMID: 35841421 PMCID: PMC9870824 DOI: 10.1007/s00262-022-03249-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2021] [Accepted: 06/24/2022] [Indexed: 01/27/2023]
Abstract
BACKGROUND Paraneoplastic leukemoid reaction (PLR) is a rare phenomenon in metastasized melanoma associated with poor prognosis and rapid disease progression. Currently, no specific therapeutic options exist other than treating the underlying malignancy. METHODS Five cases of paraneoplastic neutrophilia in patients with advanced-stage IV melanoma were enrolled in our study. Cytokine concentrations in patients' serum samples were analyzed before and during PLR using a multiplex cytokine array. Further, immunohistochemical staining of tumor tissue biopsied during PLR was performed. RESULTS AND CONCLUSIONS We observed a strong correlation between worsening of tumor burden and aggravation of neutrophilia. Cytokine measurements revealed an increase of proinflammatory cytokines (IL6, IFNγ), proangiogenic cytokines (VEGF) and immune stem cell growth factors (G-CSF) during PLR. Immunohistochemistry confirmed neutrophil infiltration of tumor tissue. The presented cytokine alterations provide a basis for further functional analysis, which is necessary for the development of targeted therapeutic approaches against PLR.
Collapse
Affiliation(s)
- Xin-Wen Zhang
- Department of Oncology and National Center for Tumor Diseases, University of Heidelberg, Im Neuenheimer Feld 460, 69120, Heidelberg, Germany.
| | - Alexander Wald
- Department of Dermatology and National Center for Tumor Diseases, University of Heidelberg, Im Neuenheimer Feld 460, 69120, Heidelberg, Germany
| | - Martin Salzmann
- Department of Dermatology and National Center for Tumor Diseases, University of Heidelberg, Im Neuenheimer Feld 460, 69120, Heidelberg, Germany
| | - Niels Halama
- Department of Oncology and National Center for Tumor Diseases, University of Heidelberg, Im Neuenheimer Feld 460, 69120, Heidelberg, Germany
| | - Jessica C Hassel
- Department of Dermatology and National Center for Tumor Diseases, University of Heidelberg, Im Neuenheimer Feld 460, 69120, Heidelberg, Germany
| |
Collapse
|
3
|
Ziccardi C, Cohn LA, Janacek B, Gross J, Nafe L, Grobman M. Etiology and outcome of extreme neutrophilic leukocytosis: A multi-institutional retrospective study of 269 dogs. J Vet Intern Med 2022; 36:541-548. [PMID: 35043992 PMCID: PMC8965212 DOI: 10.1111/jvim.16344] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/10/2021] [Revised: 12/04/2021] [Accepted: 12/08/2021] [Indexed: 11/27/2022] Open
Abstract
Background The magnitude of diagnostic abnormalities can influence the perception of clinical outcome. Extreme neutrophilic leukocytosis (ENL) is an uncommon finding caused by markedly increased granulopoiesis. A lack of recent, large‐scale studies limits our understanding of the importance, causation, and prognosis associated with ENL in dogs. Hypothesis/Objectives Describe disease categories (DC) identified in dogs with ENL and identify variables associated with survival. We hypothesized that factors including fever, segmented and band neutrophil counts, and DC would be negatively associated with survival. Animals Two‐hundred sixty‐nine dogs with ENL (segmented neutrophils ≥50 × 103 cells/μL) presented to the veterinary teaching hospitals at Auburn University (n = 164), the University of Missouri (n = 81), and Oklahoma State University (n = 24) between January 1, 2009 and December 31, 2019. Methods Retrospective study. Demographic data and outcome variables including temperature, CBC findings, DC, duration of hospitalization (DOH) and outcome were acquired from the medical record. Statistical analyses included chi‐squared and Kruskal‐Wallis tests, and Pearson product moment correlations with a P < .05 significance level. Results Mortality was 41%. Survival differed with DC (P = .002). Mortality was higher (P < .05) in dogs with neoplasia (56.2%) vs immune‐mediated disease (20.5%) or tissue damage/necrosis (19%). Weight (P = .001, r = −0.14) and total neutrophil count (P = .04, r = −0.02) were weakly negatively associated with survival whereas DOH was weakly positively associated with survival (P = .03, r = 0.14). Conclusions and Clinical Importance Mortality in dogs with ENL is high but differed according to DC. Only weak correlations between clinical or clinicopathologic variables and mortality were identified. Extreme neutrophilic leukocytosis should be interpreted in conjunction with the underlying disease process, and not broadly used to predict clinical outcome.
Collapse
Affiliation(s)
- Christianna Ziccardi
- Department of Clinical Sciences, Auburn University College of Veterinary Medicine, Auburn, Alabama, USA
| | - Leah A Cohn
- Department of Veterinary Medicine and Surgery, University of Missouri College of Veterinary Medicine, Columbia, Missouri, USA
| | - Blakeley Janacek
- Department of Veterinary Medicine and Surgery, University of Missouri College of Veterinary Medicine, Columbia, Missouri, USA
| | - Jacklyn Gross
- Department of Veterinary Clinical Sciences, Oklahoma State University College of Veterinary Medicine, Stillwater, Oklahoma, USA
| | - Laura Nafe
- Department of Veterinary Clinical Sciences, Oklahoma State University College of Veterinary Medicine, Stillwater, Oklahoma, USA
| | - Megan Grobman
- Department of Clinical Sciences, Auburn University College of Veterinary Medicine, Auburn, Alabama, USA.,Department of Veterinary Medicine and Surgery, University of Missouri College of Veterinary Medicine, Columbia, Missouri, USA
| |
Collapse
|
4
|
Azzam O, Hewavitharana CH, Fermoyle S, Prentice D. Paraneoplastic leukemoid reaction in a localised squamous cell oesophageal cancer with paracrine G-CSF production. BMJ Case Rep 2020; 13:13/10/e235069. [PMID: 33040032 PMCID: PMC7552795 DOI: 10.1136/bcr-2020-235069] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
Abstract
A 51-year-old-man presented with symptoms and baseline investigations suggestive of an infective process. Most strikingly, there was a pronounced neutrophil predominant leucocytosis. Lack of a clinical and biochemical response to empirical antibiotic therapy, prompted imaging for a deep-seated infective process, incidentally uncovering a gastro-oesophageal junction tumour. Resection of the tumour was followed by rapid resolution of the leucocytosis. He remains in clinical remission since tumour resection and adjuvant chemotherapy. Cancer-associated leukemoid reactions in non-disseminated tumours are rare. The role of polymorphonuclear (PMN) leucocytes both in the peripheral blood and the tumour itself is discussed herein. There is increasing recognition of the importance of the non-cancer cellular components of the tumour microenvironment. Myeloid suppressor cells are a subset of PMN leucocytes which play a role in tumour progression.The role of these cells and granulocyte colony-stimulating factor is highlighted in this case.
Collapse
Affiliation(s)
- Omar Azzam
- Internal Medicine, Royal Perth Hospital, Perth, Western Australia, Australia
| | | | - Soraya Fermoyle
- Department of Anatomical Pathology, Fiona Stanley Hospital, Murdoch, Western Australia, Australia
| | - David Prentice
- Internal Medicine, Royal Perth Hospital, Perth, Western Australia, Australia
| |
Collapse
|
5
|
Li P, Lu M, Shi J, Hua L, Gong Z, Li Q, Shultz LD, Ren G. Dual roles of neutrophils in metastatic colonization are governed by the host NK cell status. Nat Commun 2020; 11:4387. [PMID: 32873795 PMCID: PMC7463263 DOI: 10.1038/s41467-020-18125-0] [Citation(s) in RCA: 74] [Impact Index Per Article: 18.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/13/2019] [Accepted: 08/04/2020] [Indexed: 12/11/2022] Open
Abstract
The role of neutrophils in solid tumor metastasis remains largely controversial. In preclinical models of solid tumors, both pro-metastatic and anti-metastatic effects of neutrophils have been reported. In this study, using mouse models of breast cancer, we demonstrate that the metastasis-modulating effects of neutrophils are dictated by the status of host natural killer (NK) cells. In NK cell-deficient mice, granulocyte colony-stimulating factor-expanded neutrophils show an inhibitory effect on the metastatic colonization of breast tumor cells in the lung. In contrast, in NK cell-competent mice, neutrophils facilitate metastatic colonization in the same tumor models. In an ex vivo neutrophil-NK cell-tumor cell tri-cell co-culture system, neutrophils are shown to potentially suppress the tumoricidal activity of NK cells, while neutrophils themselves are tumoricidal. Intriguingly, these two modulatory effects by neutrophils are both mediated by reactive oxygen species. Collectively, the absence or presence of NK cells, governs the net tumor-modulatory effects of neutrophils. The role of neutrophils in the regulation of tumour growth and metastasis remains controversial. Here, the authors demonstrate that neutrophils, by exerting inhibitory effects on cytotoxic NK cells, show a net pro-metastatic effect in immune-competent mice, while they are tumoricidal and anti-metastatic in NK cell-deficient hosts.
Collapse
Affiliation(s)
- Peishan Li
- Key Laboratory of Experimental Teratology, Ministry of Education and Department of Molecular Medicine and Genetics, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, 250012, Jinan, Shandong, China.,The Jackson Laboratory, Bar Harbor, ME, 04609, USA
| | - Ming Lu
- The Jackson Laboratory, Bar Harbor, ME, 04609, USA.,Department of General Surgery, Huashan Hospital, Cancer Metastasis Institute, Fudan University, 200040, Shanghai, China
| | - Jiayuan Shi
- The Jackson Laboratory, Bar Harbor, ME, 04609, USA
| | - Li Hua
- The Jackson Laboratory, Bar Harbor, ME, 04609, USA
| | - Zheng Gong
- The Jackson Laboratory, Bar Harbor, ME, 04609, USA
| | - Qing Li
- The Jackson Laboratory, Bar Harbor, ME, 04609, USA
| | | | - Guangwen Ren
- The Jackson Laboratory, Bar Harbor, ME, 04609, USA.
| |
Collapse
|
6
|
Fredeau L, Bohelay G, Shourick J, Piver D, Guyot A, Schlageter MH, Caux F, Maubec E. Paraneoplastic neutrophilic leukaemoid reaction in a patient with melanoma: association between tumour volume and leucocytosis. Br J Dermatol 2020; 183:579-580. [PMID: 32232827 DOI: 10.1111/bjd.19059] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Affiliation(s)
- L Fredeau
- Department of Dermatology, Assistance Publique des Hôpitaux de Paris (AP-HP), Avicenne Hospital, Bobigny, France
| | - G Bohelay
- Department of Dermatology, Assistance Publique des Hôpitaux de Paris (AP-HP), Avicenne Hospital, Bobigny, France.,INSERM UMR 1125, University Paris 13, Bobigny, France
| | | | - D Piver
- Department of Radiology, Assistance Publique des Hôpitaux de Paris (AP-HP), Avicenne Hospital, Bobigny, France
| | - A Guyot
- Department of Dermatology, Assistance Publique des Hôpitaux de Paris (AP-HP), Avicenne Hospital, Bobigny, France
| | - M-H Schlageter
- AP-HP, Laboratory of Cell Biology, Saint Louis Hospital, Paris, France
| | - F Caux
- Department of Dermatology, Assistance Publique des Hôpitaux de Paris (AP-HP), Avicenne Hospital, Bobigny, France.,INSERM UMR 1125, University Paris 13, Bobigny, France
| | - E Maubec
- Department of Dermatology, Assistance Publique des Hôpitaux de Paris (AP-HP), Avicenne Hospital, Bobigny, France.,INSERM UMR 1125, University Paris 13, Bobigny, France
| |
Collapse
|
7
|
Horak V, Palanova A, Cizkova J, Miltrova V, Vodicka P, Kupcova Skalnikova H. Melanoma-Bearing Libechov Minipig (MeLiM): The Unique Swine Model of Hereditary Metastatic Melanoma. Genes (Basel) 2019; 10:E915. [PMID: 31717496 PMCID: PMC6895830 DOI: 10.3390/genes10110915] [Citation(s) in RCA: 16] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/01/2019] [Revised: 10/31/2019] [Accepted: 11/07/2019] [Indexed: 12/12/2022] Open
Abstract
National cancer databases document that melanoma is the most aggressive and deadly cutaneous malignancy with worldwide increasing incidence in the Caucasian population. Around 10% of melanomas occur in families. Several germline mutations were identified that might help to indicate individuals at risk for preventive interventions and early disease detection. More than 50% of sporadic melanomas carry mutations in Ras/Raf/mitogen-activated protein kinase (MAPK/MEK) pathway, which may represent aims of novel targeted therapies. Despite advances in targeted therapies and immunotherapies, the outcomes in metastatic tumor are still unsatisfactory. Here, we review animal models that help our understanding of melanoma development and treatment, including non-vertebrate, mouse, swine, and other mammal models, with an emphasis on those with spontaneously developing melanoma. Special attention is paid to the melanoma-bearing Libechov minipig (MeLiM). This original swine model of hereditary metastatic melanoma enables studying biological processes underlying melanoma progression, as well as spontaneous regression. Current histological, immunohistochemical, biochemical, genetic, hematological, immunological, and skin microbiome findings in the MeLiM model are summarized, together with development of new therapeutic approaches based on tumor devitalization. The ongoing study of molecular and immunological base of spontaneous regression in MeLiM model has potential to bring new knowledge of clinical importance.
Collapse
Affiliation(s)
| | | | | | | | | | - Helena Kupcova Skalnikova
- Czech Academy of Sciences, Institute of Animal Physiology and Genetics, Laboratory of Applied Proteome Analyses and Research Center PIGMOD, 277 21 Libechov, Czech Republic; (V.H.); (A.P.); (J.C.); (V.M.); (P.V.)
| |
Collapse
|
8
|
Gambichler T, Stockfleth E, Susok L. Paraneoplastic hyperleucocytosis in a melanoma patient after initiation of ipilimumab and nivolumab combination therapy. J Immunother Cancer 2018; 6:113. [PMID: 30376886 PMCID: PMC6208032 DOI: 10.1186/s40425-018-0430-y] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/16/2018] [Accepted: 10/11/2018] [Indexed: 11/10/2022] Open
Abstract
Background Paraneoplastic hyperleucocytosis (PH) is sporadically seen in patients with advanced solid tumors. Case presentation We report a female patient with disseminated melanoma metastases. Two days after the first dosage of combined immunotherapy using the cytotoxic T lymphocyte antigen-4 (CTLA-4) blocker ipilimumab and the programmed death receptor-1 (PD-1) blocker nivolumab the patient developed asymptomatic hyperleucocytosis (over 120.000 leucocytes per μl) associated with elevated granulocyte colony-stimulating factor blood levels. Hematological and infectious disorders could be ruled out. Although paraneoplastic hyperleucocytosis spontaneously resolved she died from progressive disease about 60 days after start of treatment. Conclusions PH is extremely rare in malignant melanoma, however, most patients who developed this complication had preceding immunotherapies such as interleukin-2. The latter observation and the fact that our patient developed PH rapidly after initiation of ipilimumab and nivolumab immunotherapy indicate an immune-mediated mechanism which may trigger PH under unknown circumstances. The development of paraneoplastic hyperleucocytosis indicates a very poor prognosis.
Collapse
Affiliation(s)
- Thilo Gambichler
- Skin Cancer Center, Department of Dermatology, Ruhr-University Bochum, Gudrunstrasse 56, 44791, Bochum, Germany.
| | - E Stockfleth
- Skin Cancer Center, Department of Dermatology, Ruhr-University Bochum, Gudrunstrasse 56, 44791, Bochum, Germany
| | - L Susok
- Skin Cancer Center, Department of Dermatology, Ruhr-University Bochum, Gudrunstrasse 56, 44791, Bochum, Germany
| |
Collapse
|
9
|
Minowa T, Kato J, Hida T, Horimoto K, Sato S, Sawada M, Takahashi H, Uhara H. Granulocyte colony-stimulating factor-producing melanoma treated with the combination of dabrafenib and trametinib. Int J Dermatol 2018; 57:e31-e33. [PMID: 29655274 DOI: 10.1111/ijd.14004] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/09/2017] [Revised: 02/12/2018] [Accepted: 03/18/2018] [Indexed: 12/01/2022]
Affiliation(s)
- T Minowa
- Department of Dermatology, Sapporo Medical University School of Medicine, Sapporo, Japan
| | - J Kato
- Department of Dermatology, Sapporo Medical University School of Medicine, Sapporo, Japan
| | - T Hida
- Department of Dermatology, Sapporo Medical University School of Medicine, Sapporo, Japan
| | - K Horimoto
- Department of Dermatology, Sapporo Medical University School of Medicine, Sapporo, Japan
| | - S Sato
- Department of Dermatology, Sapporo Medical University School of Medicine, Sapporo, Japan
| | - M Sawada
- Department of Dermatology, Sapporo Medical University School of Medicine, Sapporo, Japan
| | - H Takahashi
- Department of Dermatology, Sapporo Medical University School of Medicine, Sapporo, Japan
| | - H Uhara
- Department of Dermatology, Sapporo Medical University School of Medicine, Sapporo, Japan
| |
Collapse
|
10
|
Kamran N, Li Y, Sierra M, Alghamri MS, Kadiyala P, Appelman HD, Edwards M, Lowenstein PR, Castro MG. Melanoma induced immunosuppression is mediated by hematopoietic dysregulation. Oncoimmunology 2017; 7:e1408750. [PMID: 29399415 PMCID: PMC5790391 DOI: 10.1080/2162402x.2017.1408750] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2017] [Revised: 11/16/2017] [Accepted: 11/17/2017] [Indexed: 01/10/2023] Open
Abstract
Tumors are associated with expansion of immunosuppressive cells such as tumor associated macrophages (TAMs), regulatory T cells (Tregs) and myeloid derived suppressor cells (MDSCs). These cells promote tumor growth, angiogenesis, metastasis and immune escape. Cancer patients frequently present symptoms such as anemia, leukocytosis and/or cytopenia; associated with poor prognosis. To uncover tumor-mediated hematopoietic abnormalities and identify novel targets that can be harnessed to improve tumor-specific immune responses, we investigated the hematopoietic stem and progenitor cell compartment in melanoma bearing mice. We show that melanoma growth results in expansion of myeloid lineages such as MDSCs, macrophages and DCs along with a reduction in mature RBCs and platelets. Mature B lymphocytes in the blood and BM of melanoma mice were also reduced. Mice bearing melanoma showed extramedullary hematopoiesis in the spleen. Increased expansion of myeloid lineages occurred directly at the level of stem and progenitor cells. The reduction in mature B lymphocytes resulted from a block at the Pro-B cell stage in the bone marrow. Addition of recombinant IL-3 to bone marrow cells resulted in the expansion of committed myeloid progenitors including common myeloid precursors, granulocyte-monocyte precursors and megakaryocyte-erythrocyte precursors. In vivo, IL-3 receptor stimulation in melanoma bearing mice using an IL-3 antibody also resulted in a robust expansion of committed myeloid progenitors and hematopoietic stem cells. Collectively our findings demonstrate that tumor growth plays a pivotal role in reprogramming the host immune system by impacting hematopoiesis directly at the level of stem cell compartment.
Collapse
Affiliation(s)
- Neha Kamran
- Department of Neurosurgery, University of Michigan Medical School, MSRB II, RM 4570 C, 1150 West Medical Center Drive, Ann Arbor, MI, USA
- Department of Cell and Developmental Biology, University of Michigan Medical School, MSRB II, RM 4570 C, 1150 West Medical Center Drive, Ann Arbor, MI, USA
| | - Youping Li
- Department of Neurosurgery, University of Michigan Medical School, MSRB II, RM 4570 C, 1150 West Medical Center Drive, Ann Arbor, MI, USA
- Department of Cell and Developmental Biology, University of Michigan Medical School, MSRB II, RM 4570 C, 1150 West Medical Center Drive, Ann Arbor, MI, USA
| | - Maria Sierra
- Department of Neurosurgery, University of Michigan Medical School, MSRB II, RM 4570 C, 1150 West Medical Center Drive, Ann Arbor, MI, USA
- Department of Cell and Developmental Biology, University of Michigan Medical School, MSRB II, RM 4570 C, 1150 West Medical Center Drive, Ann Arbor, MI, USA
| | - Mahmoud S. Alghamri
- Department of Neurosurgery, University of Michigan Medical School, MSRB II, RM 4570 C, 1150 West Medical Center Drive, Ann Arbor, MI, USA
- Department of Cell and Developmental Biology, University of Michigan Medical School, MSRB II, RM 4570 C, 1150 West Medical Center Drive, Ann Arbor, MI, USA
| | - Padma Kadiyala
- Department of Neurosurgery, University of Michigan Medical School, MSRB II, RM 4570 C, 1150 West Medical Center Drive, Ann Arbor, MI, USA
- Department of Cell and Developmental Biology, University of Michigan Medical School, MSRB II, RM 4570 C, 1150 West Medical Center Drive, Ann Arbor, MI, USA
| | - Henry D. Appelman
- Department of Pathology, University of Michigan Medical School, 5220 Med Sci I, Ann Arbor, MI, USA
| | - Marta Edwards
- Department of Neurosurgery, University of Michigan Medical School, MSRB II, RM 4570 C, 1150 West Medical Center Drive, Ann Arbor, MI, USA
- Department of Cell and Developmental Biology, University of Michigan Medical School, MSRB II, RM 4570 C, 1150 West Medical Center Drive, Ann Arbor, MI, USA
| | - Pedro R. Lowenstein
- Department of Neurosurgery, University of Michigan Medical School, MSRB II, RM 4570 C, 1150 West Medical Center Drive, Ann Arbor, MI, USA
- Department of Cell and Developmental Biology, University of Michigan Medical School, MSRB II, RM 4570 C, 1150 West Medical Center Drive, Ann Arbor, MI, USA
| | - Maria G. Castro
- Department of Neurosurgery, University of Michigan Medical School, MSRB II, RM 4570 C, 1150 West Medical Center Drive, Ann Arbor, MI, USA
- Department of Cell and Developmental Biology, University of Michigan Medical School, MSRB II, RM 4570 C, 1150 West Medical Center Drive, Ann Arbor, MI, USA
| |
Collapse
|
11
|
Nakamura Y, Ishikawa K, Kai Y, Shimada H, Kawano M, Iwasaki T, Tagomori H, Tanata K, Tsumura H, Arakane M, Nishida H, Yokoyama S, Hatano Y, Fujiwara S. Case of malignant melanoma that developed the ability to secrete granulocyte colony-stimulating factor. J Dermatol 2016; 43:580-2. [PMID: 26777544 DOI: 10.1111/1346-8138.13240] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Yusuke Nakamura
- Department of Dermatology, Faculty of Medicine, Oita University, Yufu, Japan
| | - Kazushi Ishikawa
- Department of Dermatology, Faculty of Medicine, Oita University, Yufu, Japan
| | - Yoshitaka Kai
- Department of Dermatology, Faculty of Medicine, Oita University, Yufu, Japan
| | - Hiromitsu Shimada
- Department of Dermatology, Faculty of Medicine, Oita University, Yufu, Japan
| | - Masanori Kawano
- Orthopedic Surgery, Faculty of Medicine, Oita University, Yufu, Japan
| | - Tatsuya Iwasaki
- Orthopedic Surgery, Faculty of Medicine, Oita University, Yufu, Japan
| | - Hiroaki Tagomori
- Orthopedic Surgery, Faculty of Medicine, Oita University, Yufu, Japan
| | - Kazuhiro Tanata
- Orthopedic Surgery, Faculty of Medicine, Oita University, Yufu, Japan
| | - Hiroshi Tsumura
- Orthopedic Surgery, Faculty of Medicine, Oita University, Yufu, Japan
| | - Motoki Arakane
- Diagnostic Pathology, Faculty of Medicine, Oita University, Yufu, Japan
| | - Haruto Nishida
- Diagnostic Pathology, Faculty of Medicine, Oita University, Yufu, Japan
| | - Shigeo Yokoyama
- Diagnostic Pathology, Faculty of Medicine, Oita University, Yufu, Japan
| | - Yutaka Hatano
- Department of Dermatology, Faculty of Medicine, Oita University, Yufu, Japan
| | - Sakuhei Fujiwara
- Department of Dermatology, Faculty of Medicine, Oita University, Yufu, Japan
| |
Collapse
|
12
|
Gouveia E, Sousa M, Passos MJ, Moreira A. Paraneoplastic leukemoid reaction in a patient with BRAF V600E-mutated metastatic malignant melanoma. BMJ Case Rep 2015; 2015:bcr-2014-208645. [PMID: 25576527 DOI: 10.1136/bcr-2014-208645] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
Abstract
A paraneoplastic leukemoid reaction is a rare condition of extreme leucocytosis in patients with solid malignancies. The differential diagnosis is often a true challenge. We present a case of a 56-year old woman with a history of stage IIIA malignant melanoma resected in 2004 that was diagnosed in May 2013 with BRAF V600E-mutated metastatic disease (left arm mass, lungs and adrenal glands). The laboratory findings revealed leucocytosis with granulocytosis that increased progressively to values up to 120.0 × 10(9)/L. After a diagnostic work-up, a diagnosis of a paraneoplastic leukemoid reaction was established. We report the response of leucocytosis to radiation and BRAF inhibitor therapy, albeit short-lived. To the best of our knowledge, this is the first case report of a paraneoplastic leukemoid reaction in metastatic melanoma with characterisation of BRAF V600 mutation status. It remains unclear whether the aggressive tumour phenotype is related to the leukemoid reaction and whether this is related to the BRAF mutation.
Collapse
Affiliation(s)
- Emanuel Gouveia
- Medical Oncology Department Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisboa, Portugal
| | - Mónica Sousa
- Medical Oncology Department Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisboa, Portugal
| | - Maria José Passos
- Medical Oncology Department Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisboa, Portugal
| | - António Moreira
- Medical Oncology Department Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisboa, Portugal
| |
Collapse
|
13
|
Aliper AM, Frieden-Korovkina VP, Buzdin A, Roumiantsev SA, Zhavoronkov A. A role for G-CSF and GM-CSF in nonmyeloid cancers. Cancer Med 2014; 3:737-46. [PMID: 24692240 PMCID: PMC4303143 DOI: 10.1002/cam4.239] [Citation(s) in RCA: 85] [Impact Index Per Article: 8.5] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/21/2013] [Revised: 02/08/2014] [Accepted: 03/04/2014] [Indexed: 12/17/2022] Open
Abstract
Granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF) modulate progression of certain solid tumors. The G-CSF- or GM-CSF-secreting cancers, albeit not very common are, however, among the most rapidly advancing ones due to a cytokine-mediated immune suppression and angiogenesis. Similarly, de novo angiogenesis and vasculogenesis may complicate adjuvant use of recombinant G-CSF or GM-CSF thus possibly contributing to a cancer relapse. Rapid diagnostic tools to differentiate G-CSF- or GM-CSF-secreting cancers are not well developed therefore hindering efforts to individualize treatments for these patients. Given an increasing utilization of adjuvant G-/GM-CSF in cancer therapy, we aimed to summarize recent studies exploring their roles in pathophysiology of solid tumors and to provide insights into some complexities of their therapeutic applications.
Collapse
Affiliation(s)
- Alexander M Aliper
- Federal Clinical Research Center of Pediatric Hematology, Oncology and Immunology, Samory Mashela 1, Moscow, 117198, Russia
| | | | | | | | | |
Collapse
|
14
|
Madalinski M, Koulaouzidis A. Collagenous colitis with mucosal tears in two proton pump inhibitors and non-steroidal naive patients who developed metachronous cancer. J Dig Dis 2013; 14:51-3. [PMID: 23134231 DOI: 10.1111/j.1751-2980.2012.00646.x] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Affiliation(s)
- Mariusz Madalinski
- Centre for Liver & Digestive Disorders, Royal Infirmary of Edinburgh, Edinburgh, UK
| | | |
Collapse
|
15
|
Current World Literature. Curr Opin Pulm Med 2011. [DOI: 10.1097/mcp.0b013e328348331c] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
16
|
Bouwhuis MG, ten Hagen TLM, Eggermont AMM. Immunologic functions as prognostic indicators in melanoma. Mol Oncol 2011; 5:183-9. [PMID: 21367679 DOI: 10.1016/j.molonc.2011.01.004] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/14/2010] [Accepted: 01/27/2011] [Indexed: 02/08/2023] Open
Abstract
Outcome in melanoma patients with advanced disease is poor and systemic treatment seems to benefit only a subset of patients. Predictive markers identifying these patients are currently not available. Early studies showed an association of immune-related side effects such as vitiligo and autoimmune thyroiditis with response to IL-2 or IFNα treatment. However, conflicting data have been reported as well, mentioning the effect of a higher rate of immune-related toxicities during prolonged administration of the drug in responders. The review discusses the prognostic significance of autoimmunity during various forms of immunotherapy and stresses the importance of correcting for guarantee-time bias. In addition, other immune-related factors which have been associated with melanoma prognosis such as, CRP, white blood cell count, absolute lymphocyte count and human leukocyte antigen will be reviewed as well. A better understanding of the immune system and the host-tumor interactions should ultimately lead to more effective treatment. A major challenge expected to be addressed in future is proving ways to uncouple tumor immunity from autoimmunity.
Collapse
Affiliation(s)
- Marna G Bouwhuis
- Department of Surgery, Division Surgical Oncology, Erasmus University Medical Center - Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
| | | | | |
Collapse
|